Insider · CIK 0001905696
Aurora Cassirer
Files at FEED (NanoVibronix, Inc.). First filing -, latest -.
In brief
Aurora Cassirer files SEC Form 4 as director at FEED (NanoVibronix, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Aurora Cassirer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | FEED NanoVibronix, Inc. | AGrant or award Option to Purchase Common Stockderivative | +20,000 | $0.00 | $0 | 20,000 | Jan 2, 2025 |
| Jan 23, 2024 | FEED NanoVibronix, Inc. | AGrant or award Option to Purchase Common Stockderivative | +16,667 | $0.00 | $0 | 16,667 | Feb 23, 2024 |
| Nov 15, 2023 | FEED NanoVibronix, Inc. | AGrant or award Option to Purchase Common Stockderivative | +3,333 | $0.00 | $0 | 3,333 | Dec 4, 2023 |
| Nov 29, 2023 | FEED NanoVibronix, Inc. | DDisposition to issuer Option to Purchase Common Stockderivative | -2,500 | $0.00 | $0 | 0 | Dec 4, 2023 |
Questions about Aurora Cassirer
Answered from the filings on this page, as of the latest one.
Is Aurora Cassirer buying or selling?
Aurora Cassirer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Aurora Cassirer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Aurora Cassirer has 0.
Where does Aurora Cassirer file Form 4?
Aurora Cassirer has filed Form 4 at FEED (NanoVibronix, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.